Quick answer
A pre-filled, single-use pen device that delivers a fixed dose of medication with the push of a button. Wegovy, Zepbound, and Mounjaro all use autoinjector pens.
Full definition
An autoinjector is a single-use, single-dose injection device that simplifies subcutaneous delivery. The user removes a cap, presses the device against the skin, and triggers the injection — typically completing in 5-10 seconds. Wegovy and Zepbound use single-dose disposable autoinjectors; Mounjaro uses a similar device. Ozempic and Saxenda use multi-dose refillable pens that require dialing the correct dose. Autoinjectors typically need refrigeration before use but can be at room temperature for a limited number of days (manufacturer-specific).
Deep dive
Autoinjector: complete reference
An autoinjector is a pre-filled, single-use device that delivers a fixed medication dose via integrated spring-loaded mechanism — designed to simplify self-administration of injectable drugs. For GLP-1 medications, autoinjectors come in two main forms: (1) integrated single-use pens like Wegovy and Zepbound autoinjectors, where the patient activates the device and the spring drives the needle + delivers the full dose automatically, and (2) dial-pens like Ozempic that require the patient to set the dose by twisting and inject manually. The autoinjector design is preferred for first-time injectors because the needle remains hidden until activation, reducing injection anxiety. Standard procedure: remove cap, place against cleaned injection site, press firmly to activate, hold for 5-10 seconds for full delivery, dispose of pen safely. Common errors include not holding long enough (partial dose), injecting through clothing (sterility risk), or repeated use of single-dose autoinjector (not designed for multi-use).
- In practice
- Wegovy autoinjector: pull off blue cap, press grey end against thigh skin, hold for 10 seconds until you hear two clicks, then dispose in sharps container.
- Clinical context
- Autoinjectors reduce injection anxiety + improve adherence vs traditional needle/syringe. Most patients adapt within 1-2 doses.
Medications
Autoinjector is most directly relevant to the following GLP-1 medications:
Related terms
- Subcutaneous Injection — An injection delivered into the fat layer just below the skin (typically abdomen, thigh, or upper ar…
- Single-Dose Vial — A small glass container holding one dose of medication, typically drawn into a syringe by the patien…
- Titration — The gradual dose escalation schedule used when starting GLP-1 therapy. Typically increases every 4 w…
Continue learning
GLP1Zoom glossary is educational reference. Definitions are summary interpretations of clinical sources and not a substitute for prescribing-information detail. Full disclaimer.
References
Glucagon-Like Peptide-1 Receptor Agonists: Mechanisms и Clinical Use (Drucker, Cell Metabolism)(2018)
Tirzepatide GIP/GLP-1 Dual Agonism: Mechanism Review (Lancet Diabetes & Endocrinology)(2021)
GLP-1 Effects on Gastric Emptying: Pharmacology Review (American J Physiology)(2020)
Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity(2015)
STEP-1 trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding et al., NEJM)(2021)
SURMOUNT-1 trial: Tirzepatide Once Weekly для Treatment of Obesity (Jastreboff et al., NEJM)(2022)
SUSTAIN-6 trial: Semaglutide and Cardiovascular Outcomes (Marso et al., NEJM)(2016)
SURPASS-2 trial: Tirzepatide vs Semaglutide в Type 2 Diabetes (Frias et al., NEJM)(2021)
LEADER trial: Liraglutide and Cardiovascular Outcomes в T2D (Marso et al., NEJM)(2016)